FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000353746> ?p ?o ?g. }

• W2000353746 endingPage "18993" @default.
• W2000353746 startingPage "18986" @default.
• W2000353746 abstract "The combined effects of hyperthermia at 44 °C and local anesthetics on apoptosis in human histiocytic lymphoma U937 cells were investigated. When the cells were exposed to hyperthermia for l0 min marginal DNA fragmentation and nuclear fragmentation were observed. In the presence of amide-type local anesthetics further enhancement was found depending on concentration. The order of the concentration required for maximum induction was the reverse order of the lipophilicity (prilocaine > lidocaine > bupivacaine). Western blotting revealed that in hyperthermia there was initial release of Ca2+ from the intracellular store site as indicated by increased expression of the type 1 inositol-1,4,5-trisphosphate receptor. However, the combination with lidocaine did not induce any further enhancement. Lidocaine enhanced the decrease in ATP content and the increase in intracellular Ca2+ concentration in individual cells induced by hyperthermia. In addition, superoxide formation, decrease in the mitochondrial membrane potential, and activation of intracellular caspase-3 were found in the cells treated with hyperthermia and lidocaine. All of these were suppressed in part in the presence of the intracellular Ca2+ ion chelator BAPTA-AM (bis-(O-aminophenoxy)-ethane-N, N, N′,N′-tetraacetic acid-acetoxymethyl). The present results indicate that local anesthetics at optimal concentrations enhance hyperthermia-induced apoptosis via Ca2+- and mitochondria-dependent pathways. Initial release of Ca2+ from intracellular store sites caused by hyperthermia and followed by the subsequent increase in the intracellular Ca2+ concentration and the additional activation of the mitochondrial caspase-dependent pathway (partly regulated by intracellular Ca2+ concentration) plays a crucial role in the enhancement of apoptosis induced by the combination of hyperthermia and lidocaine. The combined effects of hyperthermia at 44 °C and local anesthetics on apoptosis in human histiocytic lymphoma U937 cells were investigated. When the cells were exposed to hyperthermia for l0 min marginal DNA fragmentation and nuclear fragmentation were observed. In the presence of amide-type local anesthetics further enhancement was found depending on concentration. The order of the concentration required for maximum induction was the reverse order of the lipophilicity (prilocaine > lidocaine > bupivacaine). Western blotting revealed that in hyperthermia there was initial release of Ca2+ from the intracellular store site as indicated by increased expression of the type 1 inositol-1,4,5-trisphosphate receptor. However, the combination with lidocaine did not induce any further enhancement. Lidocaine enhanced the decrease in ATP content and the increase in intracellular Ca2+ concentration in individual cells induced by hyperthermia. In addition, superoxide formation, decrease in the mitochondrial membrane potential, and activation of intracellular caspase-3 were found in the cells treated with hyperthermia and lidocaine. All of these were suppressed in part in the presence of the intracellular Ca2+ ion chelator BAPTA-AM (bis-(O-aminophenoxy)-ethane-N, N, N′,N′-tetraacetic acid-acetoxymethyl). The present results indicate that local anesthetics at optimal concentrations enhance hyperthermia-induced apoptosis via Ca2+- and mitochondria-dependent pathways. Initial release of Ca2+ from intracellular store sites caused by hyperthermia and followed by the subsequent increase in the intracellular Ca2+ concentration and the additional activation of the mitochondrial caspase-dependent pathway (partly regulated by intracellular Ca2+ concentration) plays a crucial role in the enhancement of apoptosis induced by the combination of hyperthermia and lidocaine. The effectiveness of hyperthermia combined with radiotherapy in the treatment of various solid tumors has been demonstrated (1Overgaard J. Int. J. Radiat. Oncol. Biol. Phys. 1989; 16: 535-549Abstract Full Text PDF PubMed Scopus (409) Google Scholar). Furthermore, recent clinical randomized trials of patients with brain tumors, recurrent or metastatic malignant melanoma, advanced breast carcinoma, locally advanced pelvic tumors, and malignant germ cell tumors clearly have indicated the advantages for patients treated with hyperthermia combined with radiotherapy (2Seegenschmiedt M.H. Feldmann H.J. Wust P. Molls M. Strahlenther. Onkol. 1995; 171: 560-572PubMed Google Scholar, 3Sneed P.K. Stauffer P.R. McDermott M.W. Diederich C.J. Lamborn K.R. Prados M.D. Chang S. Weaver K.A. Spry L. Malec M.K. Lamb S.A. Voss B. Davis R.L. Wara W.M. Larson D.A. et al.Int. J. Radiat. Oncol. Biol. Phys. 1998; 40: 287-295Abstract Full Text PDF PubMed Scopus (336) Google Scholar, 4Overgaard J. Gonzalez Gonzalez D. Hulshof M.C.C.H. Arcangeli G. Dahl O. Mella O. Bentzen S. Int. J. Hyperth. 1996; 12: 3-20Crossref PubMed Scopus (207) Google Scholar, 5Vernon C.C. Hand J.W. Field S.B. Machin D. Whaley J.B. van der Zee J. van Putten W.L. van Rhoon G.C. van Dijk J.D. Gonzalez Gonzalez D. Liu F.F. Goodman P. Sherar M. Int. J. Radiat. Oncol. Biol. Phys. 1996; 35: 731-744Abstract Full Text PDF PubMed Scopus (632) Google Scholar, 6van der Zee J. Gonzalez Gonzalez D. van Rhoon G.C. van Dijk J.D. van Putten W.L. Hart A.A. Lancet. 2000; 355: 1119-1125Abstract Full Text Full Text PDF PubMed Scopus (804) Google Scholar) or chemotherapy (7Wessalowski R. Kruck H. Pape H. Kahn T. Willers R. Gobel U. Cancer. 1998; 82: 793-800Crossref PubMed Scopus (40) Google Scholar) compared with radiotherapy alone. However, the uniform and precise delivery of heat to tumors still remains a challenge. In many circumstances the tumor cell killing is insufficient. Drugs that have been discussed as overcoming this difficulty are heat sensitizers. An ideal sensitizer would be nontoxic at normothermia but could become cytotoxic at hyperthermic temperatures. Local anesthetics belong to a class of clinically useful compounds that exert a pharmacological effect by blocking nerve impulse propagation. The involvement of cell membranes as the site for these drug actions has been widely accepted, and many reports showing modification of cell killing due to hyperthermia by LAs 1The abbreviations used are: LAlocal anestheticBAPTA-AMbis-(O-aminophenoxy)-ethane-N, N, N′,N′-tetraacetic acid-acetoxymethylPBSphosphate-buffered salinePIpropidium iodideFITCfluorescein isothiocyanateIRinhibition rateHRHEPES-buffer Ringer solutionMMPmitochondrial membrane potentialIP3Rinositol-1,4,5-trisphosphate receptorDiOC6(3)3,3-deoxycarbocyanene iodide 1The abbreviations used are: LAlocal anestheticBAPTA-AMbis-(O-aminophenoxy)-ethane-N, N, N′,N′-tetraacetic acid-acetoxymethylPBSphosphate-buffered salinePIpropidium iodideFITCfluorescein isothiocyanateIRinhibition rateHRHEPES-buffer Ringer solutionMMPmitochondrial membrane potentialIP3Rinositol-1,4,5-trisphosphate receptorDiOC6(3)3,3-deoxycarbocyanene iodide have been published (e.g. potentiation by procaine in murine L5178Y lymphoma cells (8Yau T.M. Radiat. Res. 1979; 80: 523-541Crossref PubMed Scopus (47) Google Scholar) and by lidocaine in murine FM3A mammary carcinoma cells (9Mizuno S. Ishida A. Cancer Res. 1982; 42: 4726-4729PubMed Google Scholar), potentiation of survival of tumor-bearing mice after hyperthermia combined with lidocaine (10Yatvin M.B. Clifton K.H. Dennis W.H. Science. 1979; 205: 195-196Crossref PubMed Scopus (63) Google Scholar), enhancement of hyperthermia-induced tumor regression by lidocaine in murine tumor models (11Clark A.W. Robins H.I. Vorpahl J.W. Yatvin M.B. Cancer Res. 1983; 43: 1716-1723PubMed Google Scholar, 12Robins H.I. Dennis W.H Slattery J. Lange T.A. Yatvin M.B. Cancer Res. 1983; 43: 3187-3191PubMed Google Scholar), and enhancement of cytotoxic effects of hyperthermia by dibucaine, tetracaine, and procaine in hepatoma tissue culture cells (13Kingston C.A. Ladha S. Manning R. Bowler K. Anticancer Res. 1993; 13: 2235-2240Google Scholar)). However, little is known about the modification and mechanism of apoptosis when hyperthermia is combined with LAs. local anesthetic bis-(O-aminophenoxy)-ethane-N, N, N′,N′-tetraacetic acid-acetoxymethyl phosphate-buffered saline propidium iodide fluorescein isothiocyanate inhibition rate HEPES-buffer Ringer solution mitochondrial membrane potential inositol-1,4,5-trisphosphate receptor 3,3-deoxycarbocyanene iodide local anesthetic bis-(O-aminophenoxy)-ethane-N, N, N′,N′-tetraacetic acid-acetoxymethyl phosphate-buffered saline propidium iodide fluorescein isothiocyanate inhibition rate HEPES-buffer Ringer solution mitochondrial membrane potential inositol-1,4,5-trisphosphate receptor 3,3-deoxycarbocyanene iodide Here we will present our recent findings that subtoxic levels of LAs enhanced hyperthermia-induced apoptosis via the Ca2+- and mitochondria-dependent pathways in human lymphoma U937 cells. Evidence for the cardinal roles of initial release of Ca2+ from intracellular store sites due to hyperthermia and the subsequent increase of [Ca2+]i and the additional activation of the mitochondrial caspase-dependent pathway in enhancement of apoptosis induced by the combination of hyperthermia and lidocaine will also be presented. In addition the potential usefulness of LAs as sensitizers of heat-induced apoptosis in cancer therapy will be discussed. The human histiocytic lymphoma cell line (U937) was obtained from the Japanese Cancer Research Resource Bank. Cells were grown in RPMI 1640 culture medium supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen) at 37 °C in humidified air with 5% CO2. The cells in log phase (doubling time is 23.5 h) were used for the experiments after confirmation that they were free from any mycoplasma contamination. We added LAs 5 min before heating, and hyperthermic treatments were performed by the immersion of plastic culture tubes containing the cell suspensions (3 ml) in a water bath (NTT-1200, Eyela, Tokyo, Japan) at 44.0 °C (± 0.05 °C). The temperature of the culture medium was monitored with a digital thermometer (#7563, YOKOGAWA, Tokyo, Japan) coupled with a 0.8-mm thermocouple. The amount of DNA extracted from cells that had undergone DNA fragmentation was assayed using the method of Sellins and Cohen (14Sellins K.S. Cohen J.J. J. Immunol. 1987; 139: 3199-3206PubMed Google Scholar) with a few modifications (15Hopcia K.L. McCarey Y.L. Sylvester F.C. Held K.D. Radiat. Res. 1996; 145: 315-323Crossref PubMed Scopus (56) Google Scholar). Briefly, the cells were lysed in a lysis buffer (10 mm Tris, 1 mm EDTA, 0.2% Triton X-100, pH 7.5) and centrifuged at 13,000 × g for 10 min. Subsequently, each DNA sample in the supernatant and the pellet was precipitated in 12.5% trichloroacetic acid at 4 °C and quantified using a diphenylamine reagent after hydrolysis in 5% trichloroacetic acid at 90 °C for 20 min. The percentage of fragmented DNA in each sample was calculated as the amount of DNA in the supernatant divided by the total DNA for that sample (supernatant plus pellet). Significance was assessed by a two-way analysis of variance followed by a Fisher's PLSD test and was assumed for p values <0.05. DNA was extracted from the treated cells using a Sepa Gene DNA extraction kit (Sanko Junyaku Co. Ltd., Tokyo, Japan) and digested with RNase A (50 μg/ml, Sigma) in TE buffer (10 mm Tris, 1 mm EDTA). The purified DNA (1–3 μg/lane) was electrophoresed for 60 min at 100 V in a 0.8% neutral agarose gel, and DNA-laddering was visualized by staining with 0.5 μg/ml ethidium bromide and UVB illumination (16Kimura C. Zhao Q.L. Kondo T. Amatsu M. Fujiwara Y. Exp. Cell Res. 1998; 239: 411-422Crossref PubMed Scopus (67) Google Scholar,17Li M. Kondo T. Zhao Q.L. Li F.J. Tanabe K. Arai Y. Zhou Z.C. Kasuya M. J. Biol. Chem. 2000; 275: 39702-39709Abstract Full Text Full Text PDF PubMed Scopus (214) Google Scholar). To identify the apoptotic cells after exposure to hyperthermia, the cells harvested after 6 h of incubation at 37 °C were washed with Dulbecco's PBS and collected by centrifugation. The cells were fixed with methanol and acetic acid (3:1) and spread on glass slides. After drying staining was performed with 3% Giemsa solution (pH 6.8) for 15 min. The apoptotic cells were determined by counting a total of 1,000 cells per sample in randomly selected areas. Because annexin V is a human protein with a molecular mass of 36 kDa and a high affinity for phosphatidylserine on the cell membrane, a FITC-labeled annexin V kit (Immunotech, Marseilles, France) was used to detect phosphatidylserine expression on the cell membrane as an end point of early apoptosis (18van Heerde W.L. de Groot P.G. Reutelingsperger C.P.M. Thromb. Haemostasis. 1995; 73: 172-179Crossref PubMed Scopus (199) Google Scholar). The samples were washed in cooled PBS at 4 °C and centrifuged at 500 × g for 5 min. The resulting pellets were adjusted to 106 cells/ml with the binding buffer from a FITC-labeled annexin V kit. FITC-labeled annexin V (5 μl) and PI (5 μl) were added to the suspension (490 μl) and mixed gently. After incubation for 10 min in the dark the cells were analyzed with a flow cytometer (Epics XL, Beckman-Coulter, Miami, FL). The cells were collected by centrifugation and washed with HR (NaCl, 118 mm; KCl, 4.7 mm; CaCl2, 2.5 mm; MgCl2, 1.13 mm; Na2HPO4, 1.0 mm; glucose, 5.5 mm, and HEPES, 10 mm). The buffer was supplemented with 0.2% bovine serum albumin (Sigma), minimal Eagle's essential amino acids (Flow Laboratories, Irvine, UK), and 2 mm l-glutamine. Approximately 3 × 105 cells in 3 ml of HR were loaded with 5 mmFura-2/AM (Dojindo Lab., Kumamoto, Japan) for 30 min at 25 °C. The cells loaded with Fura-2/AM were washed once with HR and twice with the growth medium. Following centrifugation the cells were transferred to a tube containing the culture medium with or without lidocaine (Sigma). After hyperthermia the cells were washed with HR, and an aliquot of cell suspensions (10 ml) was transferred onto a glass-bottomed dish coated with Cell-Tak (Genome Therapeutics). After addition of HR to the dish, digital imaging of Fura-2 fluorescence was carried out using an inverted microscope and a digital image processor (Argus 50/Ca, Hamamatsu Photonics, Hamamatsu, Japan) as reported previously (19Habara H. Kanno T. Cell Calcium. 1991; 12: 533-542Crossref PubMed Scopus (53) Google Scholar, 20Kondo T. Kano E. Habara Y. Kanno T. Cell Calcium. 1993; 14: 621-629Crossref PubMed Scopus (20) Google Scholar, 21Kameda K. Kondo T. Tanabe K. Zhao Q.L. Seto H. Int. J. Radiat. Oncol. Biol. Phys. 2001; 49: 1369-1379Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar). The fluorescence ratio (340 nm/380 nm) at 510 nm of emission wavelength was converted to [Ca2+]i using the equation of Grynkiewicz et al. (22Grynkiewicz G. Poenie M. Tsien R.Y. J. Biol. Chem. 1985; 260: 3440-3450Abstract Full Text PDF PubMed Scopus (80) Google Scholar). Significance was assessed by Mann-Whitney test and was assumed for p values <0.05. DiOC6(3) was employed for examining MMP. After treatment with hyperthermia combined with or without lidocaine cells were washed twice with PBS and were exposed to 40 nmDiOC6(3) (Wako Pure Chemical, Tokyo, Japan) in 1 ml PBSF (PBS plus 1% fetal bovine serum) for 15 min at 37 °C. The fraction of cells showing low MMP was measured by flow cytometry. The cells were lysed at a density of 106 cells per 20 μl of lysis buffer (50 mm Tris-HCl, 150 mm NaCl, 1% Nonidet P-40 (v/v), 1% sodium deoxycholate, 0.05% SDS, 1 mmphenylmethyl sulfonyl fluoride) for 20 min. After brief sonication the lysates were centrifuged, and protein content in the supernatant was measured using a Bio-Rad protein system. Western blot analyses of IP3R (1Overgaard J. Int. J. Radiat. Oncol. Biol. Phys. 1989; 16: 535-549Abstract Full Text PDF PubMed Scopus (409) Google Scholar, 3Sneed P.K. Stauffer P.R. McDermott M.W. Diederich C.J. Lamborn K.R. Prados M.D. Chang S. Weaver K.A. Spry L. Malec M.K. Lamb S.A. Voss B. Davis R.L. Wara W.M. Larson D.A. et al.Int. J. Radiat. Oncol. Biol. Phys. 1998; 40: 287-295Abstract Full Text PDF PubMed Scopus (336) Google Scholar) and β-actin were performed using specific polyclonal or monoclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA). Superoxide anion levels were measured using the method employed by Gorman et al. (23Gorman A. McGowan A. Cotter T.G. FEBS Lett. 1997; 404: 27-33Crossref PubMed Scopus (206) Google Scholar). We used the dye, hydroethidine (Molecular Probes, Eugene, OR) which is oxidized by superoxide anion radicals within the cell, which fluoresces when it intercalates into DNA. Briefly, the cells (106 cells/ml) were incubated with 2 μm hydroethidine for 15 min at 37 °C. After a second washing levels of the intracellular superoxide anion radicals were assessed using flow cytometry. The cell-permeable fluorogenic substrate (PhiPhiLux-G1D2) was used to monitor the intracellular caspase-3 activity according to the manufacturer's recommendations (OncoImmunin, Inc., Gaithersburg, MD). Briefly, the sample (106 cells/ml) was gently centrifuged, and the cell pellet was resuspended with 50 μl of 10 μm PhiPhiLux-G1D2 substrate solution in RPMI 1640 supplemented with 10% fetal bovine serum. After incubation for 1 h at 37 °C in the dark the samples were washed once and diluted with 0.5 ml of ice-cold flow cytometry dilution buffer. The fraction of cells showing high caspase-3 activities was measured by flow cytometry (24Zapta J.M. Takahashi R. Salvesen G.S. Reed J.C. J. Biol. Chem. 1998; 273: 6916-6920Abstract Full Text Full Text PDF PubMed Scopus (118) Google Scholar). Intracellular ATP level was measured using a CheckLite plus 250 kit (Kikkoman, Tokyo, Japan). After treatment the cells were centrifuged at 1,000 rpm for 2 min, and the filtrate was removed. A cell suspension (2 × 105 cells/200 μl) was added to the lysis buffer (200 μl) and was kept for 5 min at 25 °C. Afterward the absorbency of ATP, which was included in 100 μl of the cell suspension, was measured by the administration of 100 μl of the emission reagent. The intracellular ATP concentration was calculated from the standard curve (from 2 × 10−7 m to 2 × 10−10 m concentration of ATP). Significance was assessed by a two-way analysis of variance followed by a Fisher's PLSD test and was assumed for p values <0.05. To study the ability of LAs to potentiate hyperthermia-induced apoptosis, DNA fragmentation was examined when U937 cells were treated with hyperthermia combined with three kinds of amide-type LAs (lidocaine, bupivacaine, or prilocaine), which have different lipophilicities. Fig. 1 shows the effects of graded concentrations of LAs on the DNA fragmentation when the cells were incubated for 6 h at 37 °C after treatment with or without hyperthermia at 44 °C for 10 min. The apparent enhancement of hyperthermia-induced DNA fragmentation by LAs was observed at concentrations of more than 0.5 mm. The order of concentration of LAs for the maximum DNA fragmentation was prilocaine > lidocaine > bupivacaine, and this was the reverse order of lipophilicity and potency as anesthetic agents (25Scurr C. Feldman S. Sone N. Scientific Foundation of Anesthesia. Year Book Medical Publishers, Inc., Chicago1990: 636-641Google Scholar). When the cells were treated with LAs at 37 °C no DNA fragmentation induced by prilocaine was observed. In contrast, lidocaine and bupivacaine increased DNA fragmentation at concentrations more than 2 and 1.5 mm, respectively. In addition, the DNA fragmentation induced by bupivacaine decreased at a concentration of 1.5 mm. Because lidocaine is more effective with less toxicity among the LAs in this study, it was used for the following experiments. The enhancement of DNA ladder formation after treatment with hyperthermia and lidocaine was observed (Fig. 2). When the samples of cells stained with Giemsa were examined under a light microscope a marked enhancement of apoptotic change in the nuclei, especially nuclear fragmentation, was observed in the samples treated with hyperthermia and lidocaine, although hyperthermia alone induced marginal changes (Fig. 3, A–D). The percentage of cells containing fragmented nuclei after the combined treatments was 3× higher than those of the samples treated with hyperthermia (Fig. 3 E). These results of DNA ladder formation and cell morphology such as chromatin condensation and nuclear fragmentation consistently revealed that lidocaine enhanced apoptosis induced by hyperthermia in U937 cells.Figure 3Apoptotic features induced by the combination with hyperthermia and lidocaine in U937 cells. After treatment with hyperthermia (44 °C, 10 min) in the presence or absence of 1 mm lidocaine, cells were incubated for 6 h at 37 °C. They were collected for Giemsa staining and examined under a microscope at a magnification of ×400. A, 37 °C;B, 37 °C with 1 mm lidocaine; C, 44 °C; D, 44 °C with 1 mm lidocaine.E, percentage of cells showing apoptotic features.Bars represent mean ± S.D. (n = 3).View Large Image Figure ViewerDownload Hi-res image Download (PPT) Flow cytometry using annexin V/FITC and PI double staining revealed that after the combined treatment of hyperthermia and lidocaine, the cells with externalized phosphatidylserine significantly increased depending on the incubation time. This phosphatidylserine externalization is an early sign of apoptosis (Fig. 4). At 6 h, the percentage of early apoptosis, i.e. annexin V(+)/PI(−) cells, induced by the combined treatment (52.0 ± 5.0, mean ± S.D., n = 3) was significantly higher than that in the cells treated with hyperthermia alone (16.3 ± 6.3). In contrast, the percentage of secondary necrosis, i.e. annexin V(+)/PI(+), was small and was less than 20% even in the cells treated with hyperthermia and lidocaine. Because U937 cells have been reported to possess a Ca2+-dependent apoptosis pathway (16Kimura C. Zhao Q.L. Kondo T. Amatsu M. Fujiwara Y. Exp. Cell Res. 1998; 239: 411-422Crossref PubMed Scopus (67) Google Scholar, 17Li M. Kondo T. Zhao Q.L. Li F.J. Tanabe K. Arai Y. Zhou Z.C. Kasuya M. J. Biol. Chem. 2000; 275: 39702-39709Abstract Full Text Full Text PDF PubMed Scopus (214) Google Scholar, 18van Heerde W.L. de Groot P.G. Reutelingsperger C.P.M. Thromb. Haemostasis. 1995; 73: 172-179Crossref PubMed Scopus (199) Google Scholar), we carried out digital imaging of Fura-2 fluorescence to examine the change in [Ca2+]i immediately after the treatment of hyperthermia combined with or without lidocaine. The average [Ca2+]i was 83.8 ± 38.7 nm in the control cells (mean ± S.D., n = 500), 77.3 ± 44.2 nm in the cells treated with lidocaine alone, 100.5 ± 61.6 nm in the cells treated with hyperthermia alone, and 140.4 ± 119.8 nm in the cells treated with hyperthermia and lidocaine. As shown in Fig. 5, E–H(histograms of [Ca2+]i in 500 randomly selected cells) the distribution in the non-treated control cells and in the cells treated with lidocaine alone was relatively uniform. In contrast when the cells were treated with hyperthermia, especially when combined with lidocaine, the number of cells containing higher [Ca2+]i increased markedly. Because the [Ca2+]i in ∼95% of control cells was less than 135 nm, the fraction of cells showing above 135 nm was calculated and evaluated for statistical significance. No significant difference in the fraction of cells containing above 135 nm between the control (3.3 ± 5.9%, mean ± S.D., n = 5) and the cells treated with lidocaine (6.0 ± 7.1%) was observed. When the cells were treated with hyperthermia the fraction of cells showing higher [Ca2+]i (16.7 ± 7.1%) increased significantly compared with the control (p < 0.05). Furthermore, when the cells were treated with hyperthermia combined with lidocaine the fraction of cells (31.0 ± 20.3%) increased significantly compared with the cells treated with hyperthermia (p < 0.01). These results indicate that lidocaine further increased the hyperthermia-induced increase in [Ca2+]i. To explore reasons why the [Ca2+]i increased when the cells were treated with hyperthermia combined with the presence or absence of lidocaine, the expression of IP3R proteins (types 1 and 3), which is known to be related to intracellular Ca2+ homeostasis (26Khan A.A. Soloski M.J. Sharp A.H. Schilling G. Sabatini D.M. Li S.H. Ross C.A. Snyder S.H. Science. 1996; 273: 503-507Crossref PubMed Scopus (240) Google Scholar, 27Jayaraman T. Marks A.R. Mol. Cell. Biol. 1997; 17: 3005-3012Crossref PubMed Scopus (231) Google Scholar), was examined. Western blotting of whole cell extracts with IP3R-specific antibody showed that proteins of IP3R1 were slightly expressed in the U937 cells and therefore the expression was increased with hyperthermia alone immediately after the treatment (Fig. 6). However, no further increase was observed in the cells treated with hyperthermia and lidocaine. In contrast, no expression of IP3R3 was detected in the control cells and in the cells treated with hyperthermia combined with the presence or absence of lidocaine. The increase in [Ca2+]i induced by hyperthermia caused by the elevation of IP3R1 expression was revealed. This finding suggests that the intracellular release of Ca2+ from store sites induced by hyperthermia is a reason for the initial increase in [Ca2+]i. To examine whether the mitochondrial caspase-dependent pathway for apoptosis is related to the enhancement of hyperthermia-induced apoptosis by lidocaine or not, we measured the MMP change, the intracellular superoxide anion radical level, and the intracellular caspase-3 activities. When the cells were treated with hyperthermia in the presence of lidocaine and incubated at 37 °C for 6 h, cells with low MMP (Fig. 7), a high level of superoxide anion radicals, and high activities of caspase-3 (Fig. 8) increased significantly. The percentage of cells with high superoxide anion radical levels was 1.8 ± 0.4% in the control cells (mean ± S.D.,n = 3), 3.9 ± 2.5% in the cells treated with lidocaine alone, 4.4 ± 0.5% in the cells treated with hyperthermia, and 57.4 ± 15.4% in the cells treated with hyperthermia and lidocaine. These results confirmed our hypothesis that the activation of mitochondria-caspase pathway is involved in the enhancement of hyperthermia-induced apoptosis by lidocaine.Figure 8Increase of caspase-3 activity after hyperthermia combined with lidocaine. After treatment with hyperthermia (44 °C, 10 min) in the presence or absence of 1 mm lidocaine, cells were incubated for 6 h at 37 °C. They were stained with PhiPhiLux-G1D2 as described under “Experimental Procedures,” and then caspase activity was measured by flow cytometry. A, 37 °C; B, 37 °C with 1 mm lidocaine; C, 44 °C; D, 44 °C with 1 mm lidocaine. E, percentage of cells showing high caspase-3 activities. Bars in figures represent mean ± S.D. (n = 3)View Large Image Figure ViewerDownload Hi-res image Download (PPT) Because apoptosis has been known to depend strongly on the intracellular concentration of ATP (28Eguchi Y. Shimizu S. Tsujimoto Y. Cancer Res. 1997; 57: 1835-1840PubMed Google Scholar, 29Eguchi Y. Srinivasan A. Tomaselli K.J. Shimizu S. Tsujimoto Y. Cancer Res. 1999; 59: 2174-2181PubMed Google Scholar) and our result shows that mitochondria are related to the enhancement of hyperthermia-induced apoptosis by lidocaine, the ATP concentration in cells treated with various concentrations of lidocaine with or without hyperthermia was measured 3 h after treatment (Fig. 9). An increasing concentration of lidocaine induced a gradual decrease in ATP concentration at 37 °C. However, hyperthermia reduced ATP concentration to a level similar to that attained when lidocaine alone was used and significantly decreased it furthermore to 11.2 ± 3.4% (mean ± S.D.,n = 4) from 100% of the control when 5 mmlidocaine was added. To examine the role of [Ca2+]i on the enhancement of hyperthermia-induced apoptosis by lidocaine, a cytosolic free Ca2+ chelator, BAPTA-AM, was utilized. When cells were treated and incubated for 6 h in the presence of BAPTA-AM at a concentration of 50 μm, the inhibition rates (IRs) by BAPTA-AM on DNA fragmentation, on the fraction of cells expressing superoxide formation, on cells with low MMP, and on cells with activated caspase-3 were obtained. IR was calculated as: IR (%) = [(FHL−FHLB)/FHL] × 100, where FHL is percent in the cells treated with hyperthermia and lidocaine and FHLB is percent in the cells treated with hyperthermia and lidocaine in the presence of BAPTA-AM. BAPTA-AM significantly reduced these end points of apoptosis induced by hyperthermia and lidocaine. The IR on DNA fragmentation, on the fraction of cells expressing superoxide formation, on cells with low mitochondria membrane potential, and on cells with activated caspase-3 are 60.9 ± 5.1% (mean ± S.D., n = 5), 50.9 ± 5.2% (mean ± S.D., n = 5), 42.9 ± 8.6% (mean ± S.D., n = 4), and 38.0 ± 17.6% (mean ± S.D., n = 3), respectively (Fig. 10). In contrast, the reduced ATP concentration in cells treated with hyperthermia and lidocaine further decreased by 75.7 ± 5.2% in the presence of BAPTA-AM. LAs have been reported to enhance cell killing induced by hyperthermia either in vitro or in vivo (10Yatvin M.B. Clifton K.H. Dennis W.H. Science. 1979; 205: 195-196Crossref PubMed Scopus (63) Google Scholar, 12Robins H.I. Dennis W.H Slattery J. Lange T.A. Yatvin M.B. Cancer Res. 1983; 43: 3187-3191PubMed Google Scholar,30Robins H.I. Dennis W.H. Martin P.A. Sondel P.M. Yatvin M.B. Steeves R.A. Cancer. 1984; 54: 2831-2835Crossref PubMed Scopus (15) Google Scholar). Previous studies have demonstrated that LAs interact extensively with the cell membrane. For example, LAs induce disorders among the lipid part of the cell membrane, fluidizing and expanding it by nonspecific binding (13Kingston C.A. Ladha S. Manning R. Bowler K. Anticancer Res. 1993; 13: 2235-2240Google Scholar, 31Ueda I. Tashiro C. Arakawa K. Anesthesiology. 1977; 46: 327-332Crossref PubMed Scopus (64) Google Scholar). LAs raise the intracellular calcium ion level (32Coss R.A. Felgar R.E. Stokes D.G. Smith N.N. Int. J. Hyperth. 1989; 5: 383-387Crossref PubMed Scopus (6) Google Scholar, 33Butterworth J.F. Strichartz G.R. Anesthesiology. 1990; 72: 711-734Crossref PubMed Scopus (714) Google Scholar), inhibit Ca2+, Mg2+-ATPase activity (34Senisterra G.A. Lepock J.R. Int. J. Hyperth. 2000; 16: 1-17Crossref PubMed Scopus (20) Google Scholar), and reduce the mitochondrial oxidative energy metabolism (35Bruno T. Gentile F.P., Di Padova M. Antonucci E. Rubiu O. Dolo V. Pavan A. Floridi A. Oncol. Res. 1998; 10: 143-150PubMed Google Scholar). However, the mechanism by which LAs potentiate hyperthermic damage to cells is not clearly understood, and little is known about the modification of hyperthermia-induced apoptosis by LAs. The present results reveal that the mechanism of enhancement of hyperthermia-induced apoptosis by lidocaine involves increasing the initial release of Ca2+ from intracellular store sites caused by hyperthermia and a subsequent increase in [Ca2+]i, and the results also reveal that activation of a mitochondria-caspase pathway is accompanied by a loss of mitochondrial membrane potential, superoxide production, and activation of caspase-3 (See Fig. 11). The cytotoxic effects of hyperthermia as measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method (13Kingston C.A. Ladha S. Manning R. Bowler K. Anticancer Res. 1993; 13: 2235-2240Google Scholar) were enhanced by subtoxic levels of anesthetics, and the potency of these effects was related to their respective lipophilicity (13Kingston C.A. Ladha S. Manning R. Bowler K. Anticancer Res. 1993; 13: 2235-2240Google Scholar, 25Scurr C. Feldman S. Sone N. Scientific Foundation of Anesthesia. Year Book Medical Publishers, Inc., Chicago1990: 636-641Google Scholar). Fluidization of the hydrophobic core of the membrane may contribute to anesthetic potentiation of heat-induced cell death (13Kingston C.A. Ladha S. Manning R. Bowler K. Anticancer Res. 1993; 13: 2235-2240Google Scholar). In addition, bupivacaine (because of its high lipophilicity) penetrated the cell membrane, reached the mitochondria to induce deep ultrastructural modifications, and lowered the MMP (35Bruno T. Gentile F.P., Di Padova M. Antonucci E. Rubiu O. Dolo V. Pavan A. Floridi A. Oncol. Res. 1998; 10: 143-150PubMed Google Scholar). In this study, the order of the concentration of LAs for the maximum DNA fragmentation at 44 °C was in the reverse order of their lipophilicity. LAs with high lipophilicity may cause much more sensitization of cells to hyperthermia by interacting with and destabilizing membranes so that fluidity is increased, because higher lipophilicity makes it easy for LAs to integrate in the cell membrane. Therefore, LAs with higher lipophilicity appear to cause greater enhancement of hyperthermia-induced apoptosis. When the cells were treated with hyperthermia and lidocaine in the range of toxic concentrations a decrease in DNA fragmentation, early apoptosis, and an increase in secondary necrosis were observed. It is well known that a fall in ATP eventually causes various cellular abnormalities, which may lead to cell death (28Eguchi Y. Shimizu S. Tsujimoto Y. Cancer Res. 1997; 57: 1835-1840PubMed Google Scholar), and changes the type of cell death from apoptosis to necrosis (29Eguchi Y. Srinivasan A. Tomaselli K.J. Shimizu S. Tsujimoto Y. Cancer Res. 1999; 59: 2174-2181PubMed Google Scholar). Therefore, it is possible that the decrease in intracellular ATP concentration is related to this change of cell death from apoptosis to necrosis. In this study the promotion of a decrease in the intracellular ATP concentration and a subsequent drop in DNA fragmentation by hyperthermia combined with lidocaine was observed. The increase in intracellular Ca2+ concentration after treatment of hyperthermia combined with lidocaine and the suppression of DNA fragmentation by a Ca2+ chelator (BAPTA-AM) suggest that a Ca2+-dependent pathway is involved in the enhancement of hyperthermia-induced apoptosis by lidocaine. The small increase in [Ca2+]i after hyperthermia appears to be caused by an initial release of Ca2+ (derived from the intracellular storage sites) because expression of IP3R1 was up-regulated immediately after hyperthermia. Subsequently, the decrease in intracellular ATP concentration facilitated by lidocaine led to a rapid decline in the Ca2+-ATPase activity, and the accumulation of intracellular Ca2+ due to an abatement of Ca2+ exclusion (33Butterworth J.F. Strichartz G.R. Anesthesiology. 1990; 72: 711-734Crossref PubMed Scopus (714) Google Scholar) appears to cause the activation of Ca2+-dependent endonucleases and proteases in apoptosis. Involvement of the mitochondrial caspase-dependent apoptosis pathway was also indicated because of the lowering of the mitochondrial membrane potential, the increase in O2− production, and the activation of intracellular caspase-3. There have been some reports that LAs alone with high lipophilicity could reach mitochondria (36Grouselle M. Tueux O. Dabadie P. Georgescaud D. Mazat J.P. Biochem. J. 1990; 271: 269-272Crossref PubMed Scopus (66) Google Scholar) and that LAs not only induce uncoupling of mitochondria by an electrophoretic mechanism but also inhibit adenine nucleotide transport in mitochondria (37Karniel M. Beitner R. Mol. Genet. Metab. 2000; 69: 40-45Crossref PubMed Scopus (29) Google Scholar). Another study has reported that LAs at high concentrations induced apoptosis and appear to be related to activation of the mitochondria-caspase pathway, but they may not interact directly with mitochondria in HL-60 cells to induce apoptosis (38Arita K. Utsumi T. Kato A. Kanno T. Kobuchi H. Inoue B. Akiyama J. Utsumi K. Biochem. Pharmacol. 2000; 60: 905-915Crossref PubMed Scopus (60) Google Scholar). Because LAs at toxic concentrations induced apoptosis dependent on the mitochondria-caspase pathway whether they interacted with the mitochondria directly or indirectly, it is possible that hyperthermia further enhanced activation of the mitochondrial caspase-dependent pathway in apoptosis induced by LAs even at lower nontoxic concentrations. To understand better the significance of the increase in [Ca2+]i in cells treated with hyperthermia and lidocaine, various parameters of the mitochondrial caspase-dependent apoptotic pathway were examined in the presence of a cytosolic free Ca2+ chelator, BAPTA-AM, at a concentration of 50 μm (because 50 μmBAPTA-AM has shown significant inhibition of hyperthermia-induced DNA fragmentation in U937 cells) (21Kameda K. Kondo T. Tanabe K. Zhao Q.L. Seto H. Int. J. Radiat. Oncol. Biol. Phys. 2001; 49: 1369-1379Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar). When cells were treated and incubated for 6 h in the presence of BAPTA-AM, enhancement of DNA fragmentation by lidocaine combined with hyperthermia was decreased by 60.9 ± 5.1%. In addition decreases in MMP, superoxide formation, and activation of intracellular caspase-3 by hyperthermia combined with lidocaine were suppressed by approximately 40–50% (Fig. 10). These results indicate that the rise in intracellular free Ca2+ takes part not only in the Ca2+-dependent pathway but also in the mitochondrial caspase-dependent pathway. In addition because a series of parameters on the mitochondrial caspase-dependent pathway in cells treated with hyperthermia and lidocaine was suppressed by BAPTA-AM, direct involvement of intracellular free Ca2+ upon the mitochondria is suggested. These results support the view that elevations in cytosolic Ca2+ act directly on mitochondria to induce the rupture of the outer membrane and the release of caspase activation proteins (reviewed in Ref. 39Green R.G. Reed J.C. Science. 1998; 281: 1309-1312Crossref PubMed Google Scholar). In contrast, the reduced intracellular ATP concentration (another parameter that relates to mitochondrial function and cell death) in the cells treated with hyperthermia and lidocaine was further decreased by 75.7 ± 5.2% in the presence of BAPTA-AM. However, when cells were treated with BAPTA-AM alone the ATP concentration was decreased very markedly by 93.2 ± 1.4%. For this reason, the relationship between the rise in intracellular free Ca2+ and the decrease in intracellular ATP concentration in the cells treated with hyperthermia combined with lidocaine has not been resolved. Therefore, the role of intracellular ATP in the mitochondrial caspase-dependent pathway cannot be fully established because BAPTA-AM did not prevent the decrease of ATP concentration. The molecular mechanism of the enhancement of apoptosis by LAs at hyperthermic temperature has not been established. However, we obtained evidence for the cardinal roles of the initial release of Ca2+ from intracellular store sites caused by hyperthermia and the subsequent increase of [Ca2+]i and for the additional activation of the mitochondrial caspase-dependent pathway, which was partly regulated by intracellular Ca2+ concentration in the enhancement of apoptosis induced by the combination of hyperthermia and lidocaine. In conclusion we present the possible effectiveness of the use of LAs in cancer treatment in combination with hyperthermia. LAs enhance hyperthermia-induced apoptosis at non-cytotoxic concentrations when applied alone. It is hoped that a better understanding of the mechanism of apoptosis induced by hyperthermia and LAs, which are well known in pharmacology and toxicology and for which there is extensive clinical experience, will lead to the development of better strategies for use in cancer therapy. We acknowledge valuable discussions with Dr. Peter Riesz, NCI, National Institutes of Health, Bethesda, Maryland and Dr. Loreto B. Feril, Department of Radiological Sciences, Faculty of Medicine, Toyama Medical and Pharmaceutical University." @default.
• W2000353746 created "2016-06-24" @default.
• W2000353746 creator A5001259201 @default.
• W2000353746 creator A5020982275 @default.
• W2000353746 creator A5025542450 @default.
• W2000353746 creator A5031003109 @default.
• W2000353746 creator A5032111975 @default.
• W2000353746 creator A5036660611 @default.
• W2000353746 creator A5052024256 @default.
• W2000353746 creator A5080907776 @default.
• W2000353746 date "2002-05-01" @default.
• W2000353746 modified "2023-10-16" @default.
• W2000353746 title "Enhancement of Hyperthermia-induced Apoptosis by Local Anesthetics on Human Histiocytic Lymphoma U937 Cells" @default.
• W2000353746 cites W1969530011 @default.
• W2000353746 cites W1980880143 @default.
• W2000353746 cites W1987276980 @default.
• W2000353746 cites W1991576659 @default.
• W2000353746 cites W1998091543 @default.
• W2000353746 cites W1998460655 @default.
• W2000353746 cites W2010293829 @default.
• W2000353746 cites W2012449496 @default.
• W2000353746 cites W2025454188 @default.
• W2000353746 cites W2025572876 @default.
• W2000353746 cites W2026499391 @default.
• W2000353746 cites W2035745510 @default.
• W2000353746 cites W2036453111 @default.
• W2000353746 cites W2041056262 @default.
• W2000353746 cites W2072749656 @default.
• W2000353746 cites W2074868615 @default.
• W2000353746 cites W2080121674 @default.
• W2000353746 cites W2088740904 @default.
• W2000353746 cites W2095454266 @default.
• W2000353746 cites W2097113830 @default.
• W2000353746 cites W2112664392 @default.
• W2000353746 cites W2113999599 @default.
• W2000353746 cites W2141260882 @default.
• W2000353746 cites W2154935750 @default.
• W2000353746 cites W2165161047 @default.
• W2000353746 cites W2265485510 @default.
• W2000353746 cites W2413075460 @default.
• W2000353746 cites W4234637425 @default.
• W2000353746 cites W4255795828 @default.
• W2000353746 cites W4376595459 @default.
• W2000353746 doi "https://doi.org/10.1074/jbc.m108084200" @default.
• W2000353746 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11861640" @default.
• W2000353746 hasPublicationYear "2002" @default.
• W2000353746 type Work @default.
• W2000353746 sameAs 2000353746 @default.
• W2000353746 citedByCount "73" @default.
• W2000353746 countsByYear W20003537462012 @default.
• W2000353746 countsByYear W20003537462013 @default.
• W2000353746 countsByYear W20003537462014 @default.
• W2000353746 countsByYear W20003537462015 @default.
• W2000353746 countsByYear W20003537462016 @default.
• W2000353746 countsByYear W20003537462017 @default.
• W2000353746 countsByYear W20003537462018 @default.
• W2000353746 countsByYear W20003537462019 @default.
• W2000353746 countsByYear W20003537462020 @default.
• W2000353746 countsByYear W20003537462021 @default.
• W2000353746 crossrefType "journal-article" @default.
• W2000353746 hasAuthorship W2000353746A5001259201 @default.
• W2000353746 hasAuthorship W2000353746A5020982275 @default.
• W2000353746 hasAuthorship W2000353746A5025542450 @default.
• W2000353746 hasAuthorship W2000353746A5031003109 @default.
• W2000353746 hasAuthorship W2000353746A5032111975 @default.
• W2000353746 hasAuthorship W2000353746A5036660611 @default.
• W2000353746 hasAuthorship W2000353746A5052024256 @default.
• W2000353746 hasAuthorship W2000353746A5080907776 @default.
• W2000353746 hasBestOaLocation W20003537461 @default.
• W2000353746 hasConcept C108634530 @default.
• W2000353746 hasConcept C126322002 @default.
• W2000353746 hasConcept C185592680 @default.
• W2000353746 hasConcept C190283241 @default.
• W2000353746 hasConcept C203014093 @default.
• W2000353746 hasConcept C2779338263 @default.
• W2000353746 hasConcept C2779949491 @default.
• W2000353746 hasConcept C43100952 @default.
• W2000353746 hasConcept C502942594 @default.
• W2000353746 hasConcept C55493867 @default.
• W2000353746 hasConcept C71924100 @default.
• W2000353746 hasConcept C98274493 @default.
• W2000353746 hasConceptScore W2000353746C108634530 @default.
• W2000353746 hasConceptScore W2000353746C126322002 @default.
• W2000353746 hasConceptScore W2000353746C185592680 @default.
• W2000353746 hasConceptScore W2000353746C190283241 @default.
• W2000353746 hasConceptScore W2000353746C203014093 @default.
• W2000353746 hasConceptScore W2000353746C2779338263 @default.
• W2000353746 hasConceptScore W2000353746C2779949491 @default.
• W2000353746 hasConceptScore W2000353746C43100952 @default.
• W2000353746 hasConceptScore W2000353746C502942594 @default.
• W2000353746 hasConceptScore W2000353746C55493867 @default.
• W2000353746 hasConceptScore W2000353746C71924100 @default.
• W2000353746 hasConceptScore W2000353746C98274493 @default.
• W2000353746 hasIssue "21" @default.
• W2000353746 hasLocation W20003537461 @default.
• W2000353746 hasOpenAccess W2000353746 @default.
• W2000353746 hasPrimaryLocation W20003537461 @default.
• W2000353746 hasRelatedWork W2000353746 @default.

• next